Streetbeat News

Price Targets

CHRS

Truist Securities analyst Robyn Karnauskas has reiterated a Buy rating on Coherus BioSciences (NASDAQ:CHRS) and maintained a $12 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:57 pm

ZS

Truist Securities analyst Joel Fishbein has reiterated a Buy rating on Zscaler (NASDAQ:ZS) and maintained a price target of $205.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:41 pm

VIRT

BofA Securities analyst Craig Siegenthaler initiated coverage on Virtu Financial, Inc. (NASDAQ:VIRT) with a Buy rating and a $20 price target, suggesting an 18% return potential. The stock is considered a bargain, trading at 15%-20% less than other financials with a depressed valuation of 5-6x 2025E EBITDA. Despite challenges from the SEC and competition, VIRT's profits have stabilized, and future growth is expected from higher retail volumes, lower interest rates, and the next bull market. The analyst forecasts EPS of $2.07 for FY23 and $2.28 for FY24, both with a 5.4% dividend yield. VIRT shares were up 0.37% to $17.83.

Portfolio Pulse from Nabaparna Bhattacharya

November 28, 2023 | 5:39 pm

ZS

JMP Securities analyst Trevor Walsh has reiterated a 'Market Outperform' rating on Zscaler (NASDAQ:ZS) and maintained a price target of $225.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:34 pm

SYF

JMP Securities analyst David Scharf has reiterated a 'Market Outperform' rating on Synchrony Financial (NYSE:SYF), maintaining a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:32 pm

CROX

Raymond James analyst Rick Patel upgraded Crocs Inc (NASDAQ:CROX) from Outperform to Strong Buy and increased the price target from $98 to $115. Patel forecasts a 10.3% revenue growth for FY23, aligning with the street view, and raised FY24 revenue growth estimates to 4% from 3%. The analyst expects HEYDUDE's growth to stabilize and return to growth in the second half of 2024. The stock's recent rise post-Q3 earnings suggests further upside, with Patel predicting a total revenue growth of 5.5-6% and an EPS of $12.65+ for FY24. CROX shares were up 4.51% at $100.50.

Portfolio Pulse from Shivani Kumaresan

November 28, 2023 | 5:31 pm

OPRT

JMP Securities analyst David Scharf has reiterated a 'Market Outperform' rating on Oportun Financial (NASDAQ:OPRT), maintaining a price target of $6.5.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:30 pm

CABA

Cantor Fitzgerald reaffirms its Buy rating and $50 price target for Cabaletta Bio (CABA), undeterred by vague FDA concerns, accepting the inherent development risks.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:30 pm

ALLK

JMP Securities analyst Jonathan Wolleben has reiterated a 'Market Outperform' rating on Allakos (NASDAQ:ALLK) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:26 pm

AFRM

Affirm Holdings Inc.'s stock (AFRM) is trading higher following an upgrade by Jefferies from 'Underperform' to 'Hold'. Additionally, Jefferies increased its price target for Affirm from $9.5 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:24 pm